Synthesis of a Series of Novel 2-Amino-5-substituted 1,3,4-oxadiazole and 1,3,4-thiadiazole Derivatives As Potential Anticancer, Antifungal and Antibacterial Agents
Overview
Affiliations
Background: Many compounds containing a five-membered heterocyclic ring display exceptional chemical properties and versatile biological activities.
Objective: The objective of the present study was to prepare the 5-substituted 2-amino-1,3,4- oxadiazole and 2-amino-1,3,4-thiadiazole derivatives and evaluate their potential anticancer, antibacterial and antifungal activities.
Methods: Twenty-seven derivatives were synthesized by iodine-mediated cyclization of semicarbazones or thiosemicarbazones obtained from condensation of semicarbazide or thiosemicarbazide and aldehydes. The structures were confirmed by H-NMR, C-NMR and MS spectra. The antibacterial and antifungal activities were evaluated by diffusion method and the anticancer activities were evaluated by MTT assay.
Results: Twenty-seven derivatives have been synthesized in moderate to good yields. A number of derivatives exhibited potential antibacterial, antifungal and anticancer activities.
Conclusion: Compounds (1b, 1e and 1g) showed antibacterial activity against Streptococcus faecalis, MSSA and MRSA with MIC value ranging between 4 to 64 μg/mL. Compound (2g) showed antifungal activity against Candida albicans (8 μg/mL) and Aspergillus niger (64 μg/mL). Compound (1o) exhibited high cytotoxic activity against HepG2 cell line (IC value 8.6 μM) which is comparable to the activity of paclitaxel, and is non-toxic on LLC-PK1 normal cell line. The structure activity relationship and molecular docking study of the synthesized compounds have also been reported.
Slusarczyk L, Rzad K, Niedzielski G, Gurba M, Chavez J, Ceresa L Sci Rep. 2024; 14(1):31870.
PMID: 39738538 PMC: 11686287. DOI: 10.1038/s41598-024-83180-2.
and antihypertensive, anti-inflammatory, and analgesic activities of Del. leaf extracts.
Pham E, Van Doan V, Le Thi T, Van Ngo C, Vo Van L Heliyon. 2024; 10(19):e38634.
PMID: 39435095 PMC: 11492254. DOI: 10.1016/j.heliyon.2024.e38634.
Budziak-Wieczorek I, Kaczmarczyk D, Rzad K, Gagos M, Stepulak A, Mysliwa-Kurdziel B Int J Mol Sci. 2024; 25(6).
PMID: 38542326 PMC: 10970551. DOI: 10.3390/ijms25063352.
Ali Z, Rehman W, Rasheed L, Alzahrani A, Ali N, Hussain R ACS Omega. 2024; 9(7):7480-7490.
PMID: 38405480 PMC: 10882623. DOI: 10.1021/acsomega.3c05854.
Kumar D, Aggarwal N, Deep A, Kumar H, Chopra H, Marwaha R Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259401 PMC: 9963071. DOI: 10.3390/ph16020254.